The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a member of the nuclear receptor superfamily of ligand-dependent transcription factors that is predominantly expressed in adipose tissue, adrenal gland and spleen. PPAR-gamma has been demonstrated to regulate adipocyte differentiation and glucose homeostasis in response to several structurally distinct compounds, including thiazolidinediones and fibrates. Naturally occurring compounds such as fatty acids and the prostaglandin D2 metabolite 15-deoxy-delta prostaglandin J2 (15d-PGJ2) bind to PPAR-gamma and stimulate transcription of target genes. Prostaglandin D2 metabolites have not yet been identified in adipose tissue, but are major products of arachidonic-acid metabolism in macrophages, raising the possibility that they might serve as endogenous PPAR-gamma ligands in this cell type. Here we show that PPAR-gamma is markedly upregulated in activated macrophages and inhibits the expression of the inducible nitric oxide synthase, gelatinase B and scavenger receptor A genes in response to 15d-PGJ2 and synthetic PPAR-gamma ligands. PPAR-gamma inhibits gene expression in part by antagonizing the activities of the transcription factors AP-1, STAT and NF-kappaB. These observations suggest that PPAR-gamma and locally produced prostaglandin D2 metabolites are involved in the regulation of inflammatory responses, and raise the possibility that synthetic PPAR-gamma ligands may be of therapeutic value in human diseases such as atherosclerosis and rheumatoid arthritis in which activated macrophages exert pathogenic effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In microglia and macrophages, PPAR␥ activation inhibits proinflammatory gene expression (Jiang et al., 1998;Ricote et al., 1998).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Ricote et al., 1998
In the citing paper
“Moreover, inhibiting nuclear factor B (NFB) decreases expression of inflammatory cytokines such as interleukin (IL)-1, tumor necrosis factor ␣ (TNF␣) or IL-6 (12).”
From MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization (2010) · cites this paper as [12]
In the citing paper
“PPAR␥ is well established for its anti-inflammatory effects in attenuating the production of pro-inflammatory mediators (12).”
From MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization (2010) · cites this paper as [12]
In the citing paper
“Next to its role in HSCs, PPAR-γ is primarily expressed in macrophages and is capable to inhibit AP-1, STAT1 and NF-κB, therefore decreasing the inflammatory response.[136]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [136]
In the citing paper
“Next to its role in HSCs, PPAR-γ is primarily expressed in macrophages and is capable to inhibit AP-1, STAT1 and NF-κB, therefore decreasing the inflammatory response.[136]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [136]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Self-citationStimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Self-citationKliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
The matrix‐degrading metalloproteinases
Matrisian, L. M. (1992) · BioEssays · doi:10.1002/bies.950140705 · Cited by 1,364
Krey, G. D., Braissant, O., L’Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., & Wahli, W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.779 · Cited by 1,221
Cited by
Items 401–500 of 1,039
Fahmi, H., Di Battista, J. A., Pelletier, J.-P., Mineau, F., Ranger, P., & Martel-Pelletier, J. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3<595::aid-anr108>3.0.co;2-8 · Cited by 203
Jiao, P., Ma, J., Feng, B., Zhang, H., Alan‐Diehl, J., Eugene‐Chin, Y., Yan, W., & Xu, H. (2011) · Obesity · doi:10.1038/oby.2010.200 · Cited by 198
PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis
Barish, G. D., Atkins, A. R., Downes, M., Olson, P., Chong, L.-W., Nelson, M., Zou, Y., Hwang, H., Kang, H., Curtiss, L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711875105 · Cited by 196
Xu, Y., Romero, R., Miller, D., Kadam, L., Mial, T. N., Plazyo, O., Garcia-Flores, V., Hassan, S. S., Xu, Z., Tarca, A. L., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502055 · Cited by 199
Ma, X., Chen, Z., Wang, L., Wang, G., Wang, Z., Dong, X., Wen, B., & Zhang, Z. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00782 · Cited by 188
Dendritic Cell Immunogenicity Is Regulated by Peroxisome Proliferator-Activated Receptor γ
Nencioni, A., Grünebach, F., Zobywlaski, A., Denzlinger, C., Brugger, W., & Brossart, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1228 · Cited by 200
Goto, T., Takahashi, N., Hirai, S., & Kawada, T. (2010) · PPAR Research · doi:10.1155/2010/483958 · Cited by 192
Resistin- and Obesity-associated Metabolic Diseases
Lazar, M. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-985897 · Cited by 195
Wakino, S., Kintscher, U., Kim, S., Yin, F., Hsueh, W. A., & Law, R. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910452199 · Cited by 201
Nitro-fatty Acid Reaction with Glutathione and Cysteine
Baker, L. M. S., Baker, P. R. S., Golin-Bisello, F., Schopfer, F. J., Fink, M., Woodcock, S. R., Branchaud, B. P., Radi, R., & Freeman, B. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704085200 · Cited by 200
Reconstitution of lethally irradiated mice by cells isolated from adipose tissue
Cousin, B., André, M., Arnaud, E., Pénicaud, L., & Casteilla, L. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00061-5 · Cited by 200
Zingarelli, B., Sheehan, M., Hake, P. W., O’Connor, M., Denenberg, A., & Cook, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6827 · Cited by 199
Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions
Michalik, L., & Wahli, W. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00030-0 · Cited by 202
PANNU, R., & SINGH, I. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.04.010 · Cited by 195
Gelman, L., Fruchart, J.-C., & Auwerx, J. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050345 · Cited by 199
Butyrate reduces colonic paracellular permeability by enhancing PPARγ activation
Kinoshita, M., Suzuki, Y., & Saito, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00294-2 · Cited by 194
Immunomodulation by Polyunsaturated Fatty Acids: Mechanisms and Effects
Stulnig, T. M. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000074898 · Cited by 198
Galli, A., Crabb, D., Price, D., Ceni, E., Salzano, R., Surrenti, C., & Casini, A. (2000) · Hepatology · doi:10.1002/hep.510310117 · Cited by 197
Lipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0035-2016 · Cited by 172
Townsend, K. P., & Praticò, D. (2005) · The FASEB Journal · doi:10.1096/fj.04-3620rev · Cited by 196
Keshamouni, V. G., Reddy, R. C., Arenberg, D. A., Joel, B., Thannickal, V. J., Kalemkerian, G. P., & Standiford, T. J. (2004) · Oncogene · doi:10.1038/sj.onc.1206885 · Cited by 195
Akbiyik, F., Ray, D. M., Gettings, K. F., Blumberg, N., Francis, C. W., & Phipps, R. P. (2004) · Blood · doi:10.1182/blood-2004-03-0926 · Cited by 191
PPAR dual agonists: Are they opening Pandora's Box?
BALAKUMAR, P., ROSE, M., GANTI, S., KRISHAN, P., & SINGH, M. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.03.002 · Cited by 190
Yamamoto, K., Ohki, R., Lee, R. T., Ikeda, U., & Shimada, K. (2001) · Circulation · doi:10.1161/hc4001.097186 · Cited by 194
PPARγ and Atherosclerosis: Effects on Cell Growth and Movement
Hsueh, W. A., & Law, R. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100261 · Cited by 191
Willoughby, D. A., Moore, A. R., Colville-Nash, P. R., & Gilroy, D. (2000) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(00)00064-3 · Cited by 189
Zhao, Y., Patzer, A., Herdegen, T., Gohlke, P., & Culman, J. (2006) · The FASEB Journal · doi:10.1096/fj.05-5007com · Cited by 188
Ogawa, S., Lozach, J., Jepsen, K., Sawka-Verhelle, D., Perissi, V., Sasik, R., Rose, D. W., Johnson, R. S., Rosenfeld, M. G., & Glass, C. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405786101 · Cited by 183
Self-citationThieringer, R., Fenyk-Melody, J. E., Le Grand, C. B., Shelton, B. A., Detmers, P. A., Somers, E. P., Carbin, L., Moller, D. E., Wright, S. D., & Berger, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1046 · Cited by 193
Ruan, H., Pownall, H. J., & Lodish, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303141200 · Cited by 185
Ma, L.-J., Marcantoni, C., Linton, M. F., Fazio, S., & Fogo, A. B. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051899.x · Cited by 191
Niino, M., Iwabuchi, K., Kikuchi, S., Ato, M., Morohashi, T., Ogata, A., Tashiro, K., & Onoé, K. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00285-5 · Cited by 188
Rubin, G., Zhao, Y., Kalus, A. M., & Simpson, E. R. (2000) · PubMed · Cited by 198
Preventive and Prophylactic Mechanisms of Action of Pomegranate Bioactive Constituents
Viladomiu, M., Hontecillas, R., Lu, P., & Bassaganya-Riera, J. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/789764 · Cited by 174
CXC Ligand 5 Is an Adipose-Tissue Derived Factor that Links Obesity to Insulin Resistance
Chavey, C., Lazennec, G., Lagarrigue, S., Clapé, C., Iankova, I., Teyssier, J., Annicotte, J.-S., Schmidt, J., Mataki, C., Yamamoto, H., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.002 · Cited by 182
PPAR-γ receptor ligands: novel therapy for pituitary adenomas
Heaney, A. P., Fernando, M., & Melmed, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16575 · Cited by 184
Feng, X., Weng, D., Zhou, F., Owen, Y. D., Qin, H., Zhao, J., WenYu, Huang, Y., Chen, J., Fu, H., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.017 · Cited by 176
Decara, J., Rivera, P., López-Gambero, A. J., Serrano, A., Pavón, F. J., Baixeras, E., Rodríguez de Fonseca, F., & Suárez, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00730 · Cited by 180
Pelton, P. D., Zhou, L., Demarest, K. T., & Burris, T. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1071 · Cited by 186
Sugawara, A., Takeuchi, K., Uruno, A., Ikeda, Y., Arima, S., Kudo, M., Sato, K., Taniyama, Y., & Ito, S. (2001) · Endocrinology · doi:10.1210/endo.142.7.8272 · Cited by 185
Inflammation and diabetic nephropathy
Mora, C., & Navarro, J. F. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0080-1 · Cited by 183
Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2
Lee, Y. K., Park, J. E., Lee, M., & Hardwick, J. P. (2018) · Liver Research · doi:10.1016/j.livres.2018.12.001 · Cited by 173
Iñiguez, M. A., Punzón, C., & Fresno, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.111 · Cited by 185
NF-κB as a therapeutic target in neurodegenerative diseases
Camandola, S., & Mattson, M. P. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.2.123 · Cited by 184
Goetze, S., Xi, X.-P., Kawano, H., Gotlibowski, T., Fleck, E., Hsueh, W. A., & Law, R. E. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199905000-00018 · Cited by 187
Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells
Clay, C. E., Namen, A. M., Atsumi, G.-I., Willingham, M. C., High, K. P., Kute, T. E., Trimboli, A. J., Fonteh, A. N., Dawson, P. A., & Chilton, F. H. (1999) · Carcinogenesis · doi:10.1093/carcin/20.10.1905 · Cited by 184
Jennewein, C., von Knethen, A., Schmid, T., & Brüne, B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066399 · Cited by 183
Endogenous Ligands for Nuclear Receptors: Digging Deeper
Schupp, M., & Lazar, M. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.182451 · Cited by 182
The Nuclear Receptor PPARs as Important Regulators of T-Cell Functions and Autoimmune Diseases
Choi, J.-M., & Bothwell, A. L. M. (2012) · Molecules and Cells · doi:10.1007/s10059-012-2297-y · Cited by 176
Biphasic and Dosage-Dependent Regulation of Osteoclastogenesis by β-Catenin
Wei, W., Zeve, D., Suh, J. M., Wang, X., Du, Y., Zerwekh, J. E., Dechow, P. C., Graff, J. M., & Wan, Y. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05980-11 · Cited by 181
Park, G. Y., & Christman, J. W. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00513.2005 · Cited by 182
Molecular docking for virtual screening of natural product databases
Ma, D.-L., Chan, D. S.-H., & Leung, C.-H. (2011) · Chem. Sci. · doi:10.1039/c1sc00152c · Cited by 175
Babaev, V. R., Yancey, P. G., Ryzhov, S. V., Kon, V., Breyer, M. D., Magnuson, M. A., Fazio, S., & Linton, M. F. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000173413.31789.1a · Cited by 178
Takano, H., Nagai, T., Asakawa, M., Toyozaki, T., Oka, T., Komuro, I., Saito, T., & Masuda, Y. (2000) · Circulation Research · doi:10.1161/01.res.87.7.596 · Cited by 181
Satoh, H., Tsukamoto, K., Hashimoto, Y., Hashimoto, N., Togo, M., Hara, M., Maekawa, H., Isoo, N., Kimura, S., & Watanabe, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.0126 · Cited by 182
Tzameli, I., Fang, H., Ollero, M., Shi, H., Hamm, J. K., Kievit, P., Hollenberg, A. N., & Flier, J. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405346200 · Cited by 178
Roles of transient receptor potential channels in pain
Stucky, C. L., Dubin, A. E., Jeske, N. A., Malin, S. A., McKemy, D. D., & Story, G. M. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.018 · Cited by 175
PPARs: Transcription Factors Controlling Lipid and Lipoprotein Metabolism
BOCHER, V., PINEDA‐TORRA, I., FRUCHART, J., & STAELS, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04258.x · Cited by 178
Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet
Motomura, W., Inoue, M., Ohtake, T., Takahashi, N., Nagamine, M., Tanno, S., Kohgo, Y., & Okumura, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.121 · Cited by 178
Rockwell, C. E., Snider, N. T., Thompson, J. T., Vanden Heuvel, J. P., & Kaminski, N. E. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019117 · Cited by 176
PPARα Activators Inhibit Tissue Factor Expression and Activity in Human Monocytes
Marx, N., Mackman, N., Schönbeck, U., Yilmaz, N., Hombach, V., Libby, P., & Plutzky, J. (2001) · Circulation · doi:10.1161/01.cir.103.2.213 · Cited by 175
Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Murata, T., He, S., Hangai, M., Ishibashi, T., Xi, X. P., Kim, S., Hsueh, W. A., Ryan, S. J., Law, R. E., & Hinton, D. R. (2000) · PubMed · Cited by 196
Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1
Materazzi, S., Nassini, R., Andrè, E., Campi, B., Amadesi, S., Trevisani, M., Bunnett, N. W., Patacchini, R., & Geppetti, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802354105 · Cited by 170
Nutritional Regulation of Porcine Bacterial-Induced Colitis by Conjugated Linoleic Acid
Hontecillas, R., Wannemeulher, M. J., Zimmerman, D. R., Hutto, D. L., Wilson, J. H., Ahn, D. U., & Bassaganya-Riera, J. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.7.2019 · Cited by 177
The Metabolic Syndrome: Peroxisome Proliferator-Activated Receptor γ and Its Therapeutic Modulation
Gurnell, M., Savage, D. B., Chatterjee, V. K. K., & O’Rahilly, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030435 · Cited by 179
Macrophage PPARγ and impaired wound healing in type 2 diabetes
Mirza, R. E., Fang, M. M., Novak, M. L., Urao, N., Sui, A., Ennis, W. J., & Koh, T. J. (2015) · The Journal of Pathology · doi:10.1002/path.4548 · Cited by 177
“Our data showing that up-regulation of Mp PPARγ activity promotes the resolution of inflammation and wound healing in DB mice are consistent with in vitro data indicating that PPARγ activity down-regulates the expression of pro-inflammatory molecules in cultured Mp [23,24], enhances the pro-angiogenic potential of end…”
ResultObesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191663.12164.77 · Cited by 176
Sheu, M. Y., Fowler, A. J., Kao, J., Schmuth, M., Fluhr, J. W., Man, M.-Q., Elias, P. M., Feingold, K. R., Schoonjans, K., & Auwerx, J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01626.x · Cited by 177
Wang, Y., Porter, W. W., Suh, N., Honda, T., Gribble, G. W., Leesnitzer, L. M., Plunket, K. D., Mangelsdorf, D. J., Blanchard, S. G., Willson, T. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.10.0545 · Cited by 171
Self-citationCyclooxygenase‐2 modulates cellular growth and promotes tumorigenesis
Trifan, O. C., & Hla, T. (2003) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2003.tb00222.x · Cited by 176
Expression of macrophage‐selective markers in human and rodent adipocytes
Khazen, W., M'Bika, J.-P., Tomkiewicz, C., Benelli, C., Chany, C., Achour, A., & Forest, C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.032 · Cited by 167
Gautier, E. L., Chow, A., Spanbroek, R., Marcelin, G., Greter, M., Jakubzick, C., Bogunovic, M., Leboeuf, M., van Rooijen, N., Habenicht, A. J., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200495 · Cited by 166
Khandoudi, N., Delerive, P., Berrebi-Bertrand, I., Buckingham, R. E., Staels, B., & Bril, A. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1507 · Cited by 174
The two faces of the 15-lipoxygenase in atherosclerosis
Wittwer, J., & Hersberger, M. (2007) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.08.001 · Cited by 168
Zenhom, M., Hyder, A., de Vrese, M., Heller, K. J., Roeder, T., & Schrezenmeir, J. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.136176 · Cited by 167
Thiazolidine-2,4-diones: Progress towards multifarious applications
Jain, V. S., Vora, D. K., & Ramaa, C. S. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.01.029 · Cited by 165
Napoli, C., de Nigris, F., Welch, J. S., Calara, F. B., Stuart, R. O., Glass, C. K., & Palinski, W. (2002) · Circulation · doi:10.1161/01.cir.0000013090.96919.fa · Cited by 174
Self-citationMicroglia Activation and Anti-inflammatory Regulation in Alzheimer’s Disease
Lue, L.-F., Kuo, Y.-M., Beach, T., & Walker, D. G. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8106-8 · Cited by 176
Siddiqui, A. M., Cui, X., Wu, R., Dong, W., Zhou, M., Hu, M., Simms, H. H., & Wang, P. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000221921.71300.bf · Cited by 174
PPARγ Ligands and ATRA Inhibit the Invasion of Human Breast Cancer Cells in vitro
Liu, H., Zang, C., Fenner, M. H., Possinger, K., & Elstner, E. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1023366117157 · Cited by 169
Minireview: Challenges and Opportunities in Development of PPAR Agonists
Wright, M. B., Bortolini, M., Tadayyon, M., & Bopst, M. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1427 · Cited by 168
Jones, D. C., Ding, X., & Daynes, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106908200 · Cited by 169
Buates, S., & Matlashewski, G. (1999) · The Journal of Infectious Diseases · doi:10.1086/314782 · Cited by 168
Zhou, G. (1998) · Molecular Endocrinology · doi:10.1210/me.12.10.1594 · Cited by 172
Covalent Peroxisome Proliferator-activated Receptor γ Adduction by Nitro-fatty Acids
Schopfer, F. J., Cole, M. P., Groeger, A. L., Chen, C.-S., Khoo, N. K. H., Woodcock, S. R., Golin-Bisello, F., Motanya, U. N., Li, Y., Zhang, J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091512 · Cited by 171
Sharma, P., Senthilkumar, R., Brahmachari, V., Sundaramoorthy, E., Mahajan, A., Sharma, A., & Sengupta, S. (2006) · Lipids in Health and Disease · doi:10.1186/1476-511x-5-1 · Cited by 171
Cheng, Y., Dong, Z., & Liu, S. (2014) · Pharmacology · doi:10.1159/000362689 · Cited by 162
Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes
Jiao, P., Chen, Q., Shah, S., Du, J., Tao, B., Tzameli, I., Yan, W., & Xu, H. (2009) · Diabetes · doi:10.2337/db07-1344 · Cited by 166
Almeida, P. E., Silva, A. R., Maya-Monteiro, C. M., Töröcsik, D., D′Ávila, H., Dezsö, B., Magalhães, K. G., Castro-Faria-Neto, H. C., Nagy, L., & Bozza, P. T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900365 · Cited by 171
Fu, M., Zhang, J., Zhu, X., Myles, D. E., Willson, T. M., Liu, X., & Chen, Y. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105490200 · Cited by 170
Self-citationHan, J., Hajjar, D. P., Tauras, J. M., Feng, J., Gotto, A. M., & Nicholson, A. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1241 · Cited by 167
Landreth, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00296-2 · Cited by 169
Ajuebor, M. N., Singh, A., & Wallace, J. L. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.1.g238 · Cited by 168
Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer’s disease
Krause, D. L., & Müller, N. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/732806 · Cited by 168
Hontecillas, R., O'Shea, M., Einerhand, A., Diguardo, M., & Bassaganya-Riera, J. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719770 · Cited by 164
Takeda, K., Ichiki, T., Tokunou, T., Funakoshi, Y., Iino, N., Hirano, K., Kanaide, H., & Takeshita, A. (2000) · Circulation · doi:10.1161/01.cir.102.15.1834 · Cited by 169
Roles of Oxidants and Redox Signaling in the Pathogenesis of Acute Respiratory Distress Syndrome
Tasaka, S., Amaya, F., Hashimoto, S., & Ishizaka, A. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1940 · Cited by 168
Diabetes and inflammation: Fundamental aspects and clinical implications
Garcia, C., Feve, B., Ferré, P., Halimi, S., Baizri, H., Bordier, L., Guiu, G., Dupuy, O., Bauduceau, B., & Mayaudon, H. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.07.001 · Cited by 159
Neuronal PPARγ Deficiency Increases Susceptibility to Brain Damage after Cerebral Ischemia
Zhao, X., Strong, R., Zhang, J., Sun, G., Tsien, J. Z., Cui, Z., Grotta, J. C., & Aronowski, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5857-08.2009 · Cited by 164
Antiinflammatory Roles of Peroxisome Proliferator–activated Receptor γ in Human Alveolar Macrophages
Asada, K., Sasaki, S., Suda, T., Chida, K., & Nakamura, H. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-740oc · Cited by 163
Metadata
- Authors
- Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K.
- Affiliations
- United States Department of Veterans Affairs (US)
- Veterans Health Administration (US)
- University of California San Diego (US)
- Corresponding author
- Glass, Christopher K.
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6662
- Pages
- 79-82
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1633340712
- Cited by
- 3,525
- References
- 27
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 34 · 2023: 44 · 2022: 59 · 2021: 84 · 2020: 73 · 2019: 65 · 2018: 89 · 2017: 82 · 2016: 86 · 2015: 95 · 2014: 113 · 2013: 106 · 2012: 137
- FWCI
- 53.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- PPARγ, macrophage activation, prostaglandin D2 metabolites, inducible nitric oxide synthase, MMP-9, scavenger receptor A, AP-1, STAT, NF-κB, transcriptional regulation, inflammation, atherosclerosis, rheumatoid arthritis, PPARγ ligands
- MeSH terms
- Bone Marrow Cells, Gene Expression Regulation, HeLa Cells, Humans, Macrophage Activation, Macrophages, Promoter Regions, Genetic, Transcription Factors, Tumor Cells, Cultured, Prostaglandin D2, Collagenases, Macrophages, Peritoneal, Receptors, Cytoplasmic and Nuclear, Inflammation Mediators, Nitric Oxide Synthase, Matrix Metalloproteinase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.